EP Patent

EP1020443A1 — Process for producing piperazinesulfonamide derivatives and salts thereof

Assigned to Azwell Inc · Expires 2000-07-19 · 26y expired

What this patent protects

A process for advantageously producing compounds of general formula (III), wherein R 1 represents hydrogen, alkyl having 1 to 6 carbon atoms, alkoxyl having 1 to 4 carbon atoms, halogen, hydroxyl, trifluoromethyl, nitro or amino, R 2 represents substituted or unsubstituted phen…

USPTO Abstract

A process for advantageously producing compounds of general formula (III), wherein R 1 represents hydrogen, alkyl having 1 to 6 carbon atoms, alkoxyl having 1 to 4 carbon atoms, halogen, hydroxyl, trifluoromethyl, nitro or amino, R 2 represents substituted or unsubstituted phenyl or pyridyl, R 3 and R 4 each represents hydrogen, alkyl having 1 to 6 carbon atoms, hydroxyalkyl having 1 to 4 carbon atoms, cycloalkyl having 3 to 8 carbon atoms, or substituted or unsubstituted phenyl; and Y represents alkylene having 1 to 12 carbon atoms, and salts thereof.

Drugs covered by this patent

Patent Metadata

Patent number
EP1020443A1
Jurisdiction
EP
Classification
Expires
2000-07-19
Drug substance claim
No
Drug product claim
No
Assignee
Azwell Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.